Press releases
- Press releases
- Browse
Press releases
HELSINN HEALTHCARE SA, a Swiss pharmaceutical group, and GALENICA, a Pharmaceutical company based in Greece, announce the signing of an agreement granting GALENICA the exclusive License agreement for Aloxi(R) (palonosetron hydrochloride) in Greece. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 148 pages - $1,740
Dec 2010 - 30 pages - $500
Dec 2010 - 41 pages - $500
Mar 2011 - 41 pages - $500
Dec 2010 - 40 pages - $500
Mar 2011 - 40 pages - $500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 324 pages - $1,495
Apr 2011 - 81 pages - $2,000
Jun 2006 - 278 pages - $2,495
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us